White label – Pompe disease - ClinicalTrials.eu

Study on Swallowing and Quality of Life in Advanced Head and Neck Cancer Patients Using Cisplatin and Drug Combination

Not recruiting

3 1 1 1
Investigated Diseases:
- Oropharyngeal cancer
Investigated Drugs:
Study on SOT102 for Patients with Advanced Gastric and Pancreatic Cancer, Alone or with Drug Combination

Not recruiting

2 1 1 1
Investigated Diseases:
- Adenocarcinoma pancreas
- Oesophageal adenocarcinoma
Investigated Drugs:
Study Comparing MK-4280A (Favezelimab and Pembrolizumab) with Chemotherapy for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

Not recruiting

2 1 1 1
Investigated Diseases:
- Hodgkin’s disease
Investigated Drugs:
+1
Study on Ravulizumab for Children with Paroxysmal Nocturnal Hemoglobinuria or Atypical Hemolytic Uremic Syndrome

Not recruiting

3 1 1 1
Investigated Diseases:
- Atypical haemolytic uraemic syndrome
- Paroxysmal nocturnal haemoglobinuria
Investigated Drugs:
- Ravulizumab
Study of Durvalumab and Tremelimumab for Patients with Advanced Liver Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Hepatocellular carcinoma
Investigated Drugs:
Study on the Effectiveness and Safety of UV1 Vaccine with or without Sargramostim for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Not recruiting

2 1 1
Investigated Diseases:
- Lung neoplasm malignant
- Non-small cell lung cancer
Investigated Drugs:
Study on Ustekinumab for Children with Moderate to Severe Ulcerative Colitis

Not recruiting

3 1 1
Investigated Drugs:
- Ustekinumab
Study on Linaclotide for Treating Functional Constipation in Children Aged 2 to 5 Years

Not recruiting

3 1
Investigated Diseases:
- Constipation
Investigated Drugs:
- Linaclotide
Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Not recruiting

3 1 1
Investigated Drugs:
+13
Study of Pembrolizumab with Chemotherapy for High-Risk Endometrial Cancer Patients After Surgery

Not recruiting

3 1 1
Investigated Drugs:
+7

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies